drug abuse
UCSD will support investigators researching the genetic underpinnings of drug abuse with specialized rats and computational tools for rat genotyping.
Cannabis Use Disorders Linked to Population-Specific Risk Loci in GWAS Meta-Analysis
Researchers flagged cannabis use disorder-associated loci in African, East Asian, European, and admixed American populations before digging into related traits and behaviors.
NIDA Awards Geisinger $973K to Study Genomics of Opioid Use Disorder
Researchers will use data from two biobanks, Geisinger's MyCode Community Health Initiative and Vanderbilt University’s BioVU.
Solvd Health Gets CE Mark for Opioid Use Disorder Risk Assessment Test
The genetic test is currently under review by the US Food and Drug Administration, which granted it a breakthrough device designation in 2018.
Prescient Medicine Acquires AutoGenomics
Prescient will further the development and commercialization of the Infiniti Neural Response Panel to identify patients who may be at risk for opioid use disorder.